SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Cognitive Neurology Consultation — Sugar Ray Robinson

PatientSugar Ray Robinson
Date of birth1963-05-03
IdentifiersMRN HR-BX003-SYN; SSN (made up) 000-03-9318
Document date2026-07-21
AuthorMireille Haddad-Kowalski, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Two years of progressive memory loss with getting lost while driving in a retired professional boxer of 63 with type 2 diabetes and hypertension; MoCA 18. Please stage the impairment, weigh Alzheimer's disease against traumatic encephalopathy syndrome and vascular disease, advise on biomarker testing and on eligibility for anti-amyloid therapy, and help us plan safety and support. [S]

Urgency: Routine; at the memory clinic two weeks from now, on the same day as his two-week primary care visit, with brain MRI and audiometry that morning. [S]

Questions for the consultant:

History of Present Illness

Sugar Ray Robinson, a retired professional boxer of 63, is seen at the memory clinic with his care partner at the request of Dr. Pryce-Okonjo. He says his memory is not what it was but that this is normal at his age; his care partner describes two years of slowly worsening forgetfulness for recent events, repeated questions and stories, missed bills, and two episodes of getting lost while driving in familiar streets. There has been no sudden change, no hallucinations, no acting out of dreams, no falls and no change in personality, temper or mood. He boxed for about 25 years; he remembers many hard fights but cannot say how often he was dazed. He exercises daily and still goes to the gym of the youth foundation he started. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

4 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metformin 1,000 mg oral tablet, one tablet twice daily with mealsOne tablet twice daily with mealsOral route2024-03-01activeS
Glipizide 5 mg oral tablet, one tablet before breakfastOne tablet before breakfastOral route2025-01-15 to 2026-08-18completedS
Lisinopril 20 mg oral tablet, one tablet dailyOne tablet dailyOral route2023-06-01activeS
Atorvastatin 20 mg oral tablet, one tablet dailyOne tablet dailyOral route2024-03-01activeS
Diphenhydramine 25 mg oral capsule, one at bedtime for sleep, bought over the counterOne capsule at bedtimeOral route2025-10-01 to 2026-07-07stoppedS

Problems

ProblemClinical statusVerificationCodeProvenance
Memory loss over about two years, worse in the past six months, with repeated questions, missed appointments and bills, and getting lost twice while driving in familiar streets, reported by him and his care partner; cause to be foundactiveconfirmed R41.3S — Synthetic presenting problem anchored to his documented Alzheimer's disease; resolved into the diagnosis at the third visit. Not a claim about his real symptoms at that age.
Type 2 diabetes for about ten years on metformin and glipizide; hemoglobin A1c 6.4%, below his goal, with hypoglycemia risk from the sulfonylureaactiveconfirmed E11.9S — Synthetic modern diabetes anchored to his documented diabetes.
Hypertension, controlled on lisinoprilactiveconfirmed I10S — Synthetic modern hypertension anchored to the single press report.
Bilateral sensorineural hearing loss, mild to moderate, high frequencies, on audiometryactiveconfirmed H90.3S — Synthetic finding checked as a modifiable contributor to cognitive difficulty.

Physical Exam

Vital signs recorded on 2026-07-21; see the referring visit's Vital Signs section. [S]

SystemFinding
NeurologicalCranial nerves normal; no rigidity, tremor, bradykinesia or dysarthria; normal strength, reflexes and coordination; steady narrow-based gait
Mental statusAlert and courteous; repeats questions; impaired delayed recall that cueing helps little; mild executive slowing; language and visuospatial copying preserved; no psychotic symptoms

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-07-21Mini-Mental State Examination [MMSE]22{score}S
2026-07-21Clinical Dementia Rating scale [CDR]1{score}S

Assessment

Data reviewed: Dr. Pryce-Okonjo's intake note. MoCA 18 at intake (education point included); PHQ-9 4; Functional Activities Questionnaire 11. Blood count, metabolic panel, B12, TSH and urine albumin-to-creatinine ratio normal; hemoglobin A1c 6.4%. Brain MRI this morning: moderate bilateral hippocampal atrophy, left more than right, mild generalized atrophy, Fazekas 1 white matter change, six microbleeds at the gray-white junction of both frontal lobes and the right temporal lobe, no cortical superficial siderosis or infarct, and a cavum septi pellucidi. Audiometry this morning: mild to moderate bilateral high-frequency sensorineural hearing loss. No anticoagulant or antiplatelet drug. Today: MMSE 22; global CDR 1, sum of boxes 5.5. [S]

Plan of Treatment